Results 121 to 130 of about 20,748 (167)

Immature Platelet Fraction as a Potential Biomarker of Dysregulated Thrombopoiesis in Philadelphia-Negative Myeloproliferative Neoplasms. [PDF]

J Clin Med
Zekanovic I, Marketin T, Moric Peric M, Zekanovic D, Vulic A, Milos M, Bogic A, Marcinkovic M, Grbic Pavlovic P, Radic Antolic M, Knezevic J, Jurlina L, Boban A.   +12 more
europepmc   +1 more source

Gupta V, Tomuleasa C, Barranco Lampón GI, et al. Real-world treatment patterns and health care resource use for patients with myelofibrosis: results from the METER study. Blood Adv. 2025;9(5):1105-1116. [PDF]

Blood Adv
europepmc   +1 more source

A rare case of extramedullary hematopoiesis: when the pericardium produces blood cells. [PDF]

Egypt Heart J
Hayar SE, Tamir M, Khaldi M, Bouziane M, Haboub M, Arous S, Bennouna MG, Drighil A, Habbal R, Mellouki A.   +9 more
europepmc   +1 more source

Clonal Progression and Leukemic Transformation of a TP53 Mutated Post-Polycythaemia Vera Myelofibrosis. [PDF]

Eur J Haematol
Minović I, Koopman B, Ploegmakers JJW, van der Logt EMJ, Cleven AHG, van der Veen A, Buijs A, Mulder AB, Ammatuna E.   +8 more
europepmc   +1 more source

Infectious retinitis associated with JAK inhibitors: the ongoing duality of JAK inhibitors. [PDF]

Int J Retina Vitreous
Pulido JS, Mano F, Casella M, Ishida S.
europepmc   +1 more source

European LeukemiaNet criteria for safety and efficacy evaluation of new drugs for myelofibrosis. [PDF]

Blood Cancer J
Marchetti M, Vannucchi AM, Mascarenhas JO, Alvarez-Larran A, Bose P, Gale RP, Harrison C, Hehlmann R, Kiladjian JJ, Koschmieder S, Mesa R, Passamonti F, Rambaldi A, Tefferi A, Barbui T.   +14 more
europepmc   +1 more source

Triple-negative primary myelofibrosis: a comparative analysis of phenotype, genotype, and outcome. [PDF]

Blood Cancer J
Bashir YA, Abdelrheem AA, Abdelmagid M, Reichard KK, He R, Zepeda Mendoza CJ, Pardanani A, Gangat N, Tefferi A.   +8 more
europepmc   +1 more source

Correction to "Novel approaches in myelofibrosis". [PDF]

Hemasphere
europepmc   +1 more source

Inflammatory mediators differentially regulate megakaryopoiesis and thrombopoiesis in myelofibrosis and essential thrombocythemia. [PDF]

Sci Rep
Yañuk DB, Cellucci AS, Marta RF, Discianni Lupi AD, De Luca G, Glembotsky AC, Rios MAC, Moiraghi B, Sackmann F, Guerrieri VC, Heller PG, Goette NP, Lev PR.   +12 more
europepmc   +1 more source